Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What long-term size projections exist for the Point-of-Care (POC) Coagulation Testing Devices Market covering 2026–2035?
The point-of-care (poc) coagulation testing devices market has seen significant expansion in recent years. It is anticipated to increase from $2.32 billion in 2025 to $2.55 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. Historically, this market’s growth can be attributed to the rising prevalence of coagulation disorders, increased use of anticoagulant therapies, the expansion of decentralized healthcare settings, the growing adoption of point-of-care diagnostics, and improvements in coagulation testing technologies.
The market for point-of-care (poc) coagulation testing devices is anticipated to show significant expansion in the upcoming years. It is projected to achieve a size of $3.49 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.2%. The expected increase during this forecast period can be linked to the rising need for home healthcare diagnostics, a greater focus on personalized medicine, the enlargement of telehealth-enabled diagnostics, the expanding geriatric demographic, and continuous innovation within microfluidic testing platforms. Prominent trends for the forecast duration include the increasing adoption of portable coagulation monitors, a surging demand for rapid diagnostic testing at the point of care, the growing utilization of home-based coagulation testing kits, an expansion of wireless data connectivity in poc devices, and an enhanced emphasis on test accuracy and reliability.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp
Which Drivers Are Impacting The Competitive Landscape Of The Point-of-Care (POC) Coagulation Testing Devices Market?
The growing incidence of blood clotting conditions is anticipated to advance the point-of-care (POC) coagulation testing devices market moving forward. Blood clotting disorders interfere with the blood’s proper clotting ability. Lifestyle elements such as smoking, excessive alcohol intake, and a sedentary routine can contribute to these disorders. These behaviors can negatively affect blood vessel health, levels of clotting factors, and blood flow, thereby elevating the risk of abnormal clot formation. POC coagulation testing devices enable healthcare providers to swiftly assess a patient’s coagulation status, allowing for timely adjustments to medication doses and treatment approaches. For instance, in July 2025, the National Blood Authority, an Australia-based blood management agency, documented 2,788 patients living with hereditary haemophilia A (HMA) in 2023–2024, an increase from 2,681 patients in 2022–2023. Thus, the escalating prevalence of blood clotting disorders is a driving factor for the growth of the point-of-care (POC) coagulation testing devices market.
What Leading Segments Are Studied In The Point-of-Care (POC) Coagulation Testing Devices Market?
The point-of-care (poc) coagulation testing devices market covered in this report is segmented –
1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Coagulation Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users
Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)
Which Trends Are Influencing The Performance And Direction Of The Point-of-Care (POC) Coagulation Testing Devices Market?
Leading firms within the point-of-care (POC) coagulation testing devices market are actively developing quantitative analyzers based on immunofluorescence technology, aiming to enhance the diagnosis and management of coagulation disorders. These immunofluorescence-based quantitative analyzers function as diagnostic tools within laboratory environments, designed to measure and quantify particular proteins or molecules integral to the coagulation process, thereby assisting in the diagnosis and treatment of blood clotting conditions. An illustrative example is Cipla Limited, an India-based pharmaceutical company, which introduced Cippoint in January 2023. Cippoint, an immunofluorescence-based quantitative analyzer, leverages immunofluorescence technology to deliver swift and precise test outcomes within a 3 to 15-minute timeframe, thus speeding up clinical decision-making. Characterized by its user-friendly interface, rapid turnaround, and broad testing capabilities, Cippoint plays a vital role in boosting diagnostic efficiency, facilitating prompt clinical choices, and ultimately improving patient care results.
Which Key Players Are Driving Competition In The Point-of-Care (POC) Coagulation Testing Devices Market?
Major companies operating in the point-of-care (poc) coagulation testing devices market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, HemoSonics LLC, Sysmex Corporation, Nihon Kohden Corporation, HORIBA Medical, Helena Laboratories Corporation, Diagnostica Stago, Sekisui Diagnostics, Instrumentation Laboratory, Trinity Biotech plc, CoaguSense Inc., iLine Microsystems, Medirox AB, Hemochron Systems, Axis-Shield Diagnostics
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Point-of-Care (POC) Coagulation Testing Devices Market?
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2025. The regions covered in the point-of-care (poc) coagulation testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Point-of-Care (POC) Coagulation Testing Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15636&type=smp
Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Devices Market 2026, By The Business Research Company
Point Of Care Poc Coagulation Testing Devices Global Market Report 2026
Point Of Care Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report
Coagulation Markers Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/coagulation-markers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company